Global Sarcopenia Supplement Market

Sarcopenia Supplement Comprehensive Study by Type (Protein Supplement, Vitamin D & Calcium Supplement, Vitamin B12 Supplement), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies) Players and Region - Global Market Outlook to 2026

Sarcopenia Supplement Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Sarcopenia Supplement Market?

Sarcopenia is described as the aging-related decrease of skeletal muscular mass or flesh. Sarcopenia is marked by muscle atrophy, relative weakness, a lack of stamina, difficulty climbing stairs, and poor balance. The rate of muscle loss is influenced by a variety of factors, including exercise level, co-morbidities, nutrition, and others. Sarcopenia can impair one's quality of life and cause disability. It is the decrease of muscular mass and strength that occurs as a natural part of the ageing process.As a result, sarcopenia has no known cure; however, appropriate nutrition and dietary supplements can aid with the illness. Due to a growth in the number of geriatrics and their use of vitamins and dietary supplements for better treatment of this ailment, the global market is expected to grow. Furthermore, expanding sarcopenia research and development endeavours will boost market expansion.

The market study is being classified by Type (Protein Supplement, Vitamin D & Calcium Supplement and Vitamin B12 Supplement) and major geographies with country level break-up.

Abbott Laborites (United States), Pfizer Inc.(United States), Novartis AG (Switzerland), GlaxoSmithKline Plc (United Kingdom), Nestlé S.A. (Switzerland), Bayer AG (Germany), Sanofi S.A. (France), Amway(United States), Cadila Healthcare Ltd.(India) and Eli Lilly and Company(United States) are some of the key players profiled in the study.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Sarcopenia Supplement market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Sarcopenia Supplement market by Type, Application and Region.

On the basis of geography, the market of Sarcopenia Supplement has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Geriatric Population
  • Malnutrition and Vitamin Deficiency in Developing Countries


Restraints
  • Side Effects Related to Drugs
  • Stringent Regulatory Factors

Opportunities
  • Growing Research and Development Activities

Challenges
  • Lack of Awareness





Key Target Audience
Drug Manufacturers and Suppliers, Academic Research Institutes, Hospitals and Clinics, Research and Development (R&D) Companies and Governmental bodies

Report Objectives / Segmentation Covered

By Type
  • Protein Supplement
  • Vitamin D & Calcium Supplement
  • Vitamin B12 Supplement
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online pharmacies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Geriatric Population
      • 3.2.2. Malnutrition and Vitamin Deficiency in Developing Countries
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Sarcopenia Supplement, by Type, Distribution Channel and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Sarcopenia Supplement (Value)
      • 5.2.1. Global Sarcopenia Supplement by: Type (Value)
        • 5.2.1.1. Protein Supplement
        • 5.2.1.2. Vitamin D & Calcium Supplement
        • 5.2.1.3. Vitamin B12 Supplement
      • 5.2.2. Global Sarcopenia Supplement by: Distribution Channel (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Online pharmacies
      • 5.2.3. Global Sarcopenia Supplement Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Sarcopenia Supplement: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laborites (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer Inc.(United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Novartis AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GlaxoSmithKline Plc (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nestlé S.A. (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bayer AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sanofi S.A. (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Amway(United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cadila Healthcare Ltd.(India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Eli Lilly and Company(United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Sarcopenia Supplement Sale, by Type, Distribution Channel and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Sarcopenia Supplement (Value)
      • 7.2.1. Global Sarcopenia Supplement by: Type (Value)
        • 7.2.1.1. Protein Supplement
        • 7.2.1.2. Vitamin D & Calcium Supplement
        • 7.2.1.3. Vitamin B12 Supplement
      • 7.2.2. Global Sarcopenia Supplement by: Distribution Channel (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Online pharmacies
      • 7.2.3. Global Sarcopenia Supplement Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Sarcopenia Supplement: by Type(USD Million)
  • Table 2. Sarcopenia Supplement Protein Supplement , by Region USD Million (2015-2020)
  • Table 3. Sarcopenia Supplement Vitamin D & Calcium Supplement , by Region USD Million (2015-2020)
  • Table 4. Sarcopenia Supplement Vitamin B12 Supplement , by Region USD Million (2015-2020)
  • Table 5. Sarcopenia Supplement: by Distribution Channel(USD Million)
  • Table 6. Sarcopenia Supplement Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 7. Sarcopenia Supplement Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 8. Sarcopenia Supplement Online pharmacies , by Region USD Million (2015-2020)
  • Table 9. South America Sarcopenia Supplement, by Country USD Million (2015-2020)
  • Table 10. South America Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 11. South America Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 12. Brazil Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 13. Brazil Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 14. Argentina Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 15. Argentina Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 16. Rest of South America Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 17. Rest of South America Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 18. Asia Pacific Sarcopenia Supplement, by Country USD Million (2015-2020)
  • Table 19. Asia Pacific Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 20. Asia Pacific Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 21. China Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 22. China Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 23. Japan Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 24. Japan Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 25. India Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 26. India Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 27. South Korea Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 28. South Korea Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 29. Taiwan Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 30. Taiwan Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 31. Australia Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 32. Australia Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 33. Rest of Asia-Pacific Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 35. Europe Sarcopenia Supplement, by Country USD Million (2015-2020)
  • Table 36. Europe Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 37. Europe Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 38. Germany Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 39. Germany Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 40. France Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 41. France Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 42. Italy Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 43. Italy Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 44. United Kingdom Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 45. United Kingdom Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 46. Netherlands Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 47. Netherlands Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 48. Rest of Europe Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 49. Rest of Europe Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 50. MEA Sarcopenia Supplement, by Country USD Million (2015-2020)
  • Table 51. MEA Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 52. MEA Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 53. Middle East Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 54. Middle East Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 55. Africa Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 56. Africa Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 57. North America Sarcopenia Supplement, by Country USD Million (2015-2020)
  • Table 58. North America Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 59. North America Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 60. United States Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 61. United States Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 62. Canada Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 63. Canada Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 64. Mexico Sarcopenia Supplement, by Type USD Million (2015-2020)
  • Table 65. Mexico Sarcopenia Supplement, by Distribution Channel USD Million (2015-2020)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Sarcopenia Supplement: by Type(USD Million)
  • Table 77. Sarcopenia Supplement Protein Supplement , by Region USD Million (2021-2026)
  • Table 78. Sarcopenia Supplement Vitamin D & Calcium Supplement , by Region USD Million (2021-2026)
  • Table 79. Sarcopenia Supplement Vitamin B12 Supplement , by Region USD Million (2021-2026)
  • Table 80. Sarcopenia Supplement: by Distribution Channel(USD Million)
  • Table 81. Sarcopenia Supplement Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 82. Sarcopenia Supplement Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 83. Sarcopenia Supplement Online pharmacies , by Region USD Million (2021-2026)
  • Table 84. South America Sarcopenia Supplement, by Country USD Million (2021-2026)
  • Table 85. South America Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 86. South America Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 87. Brazil Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 88. Brazil Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 89. Argentina Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 90. Argentina Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 91. Rest of South America Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 92. Rest of South America Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 93. Asia Pacific Sarcopenia Supplement, by Country USD Million (2021-2026)
  • Table 94. Asia Pacific Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 95. Asia Pacific Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 96. China Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 97. China Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 98. Japan Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 99. Japan Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 100. India Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 101. India Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 102. South Korea Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 103. South Korea Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 104. Taiwan Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 105. Taiwan Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 106. Australia Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 107. Australia Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 108. Rest of Asia-Pacific Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 109. Rest of Asia-Pacific Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 110. Europe Sarcopenia Supplement, by Country USD Million (2021-2026)
  • Table 111. Europe Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 112. Europe Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 113. Germany Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 114. Germany Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 115. France Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 116. France Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 117. Italy Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 118. Italy Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 119. United Kingdom Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 120. United Kingdom Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 121. Netherlands Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 122. Netherlands Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 123. Rest of Europe Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 124. Rest of Europe Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 125. MEA Sarcopenia Supplement, by Country USD Million (2021-2026)
  • Table 126. MEA Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 127. MEA Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 128. Middle East Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 129. Middle East Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 130. Africa Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 131. Africa Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 132. North America Sarcopenia Supplement, by Country USD Million (2021-2026)
  • Table 133. North America Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 134. North America Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 135. United States Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 136. United States Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 137. Canada Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 138. Canada Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 139. Mexico Sarcopenia Supplement, by Type USD Million (2021-2026)
  • Table 140. Mexico Sarcopenia Supplement, by Distribution Channel USD Million (2021-2026)
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Sarcopenia Supplement: by Type USD Million (2015-2020)
  • Figure 5. Global Sarcopenia Supplement: by Distribution Channel USD Million (2015-2020)
  • Figure 6. South America Sarcopenia Supplement Share (%), by Country
  • Figure 7. Asia Pacific Sarcopenia Supplement Share (%), by Country
  • Figure 8. Europe Sarcopenia Supplement Share (%), by Country
  • Figure 9. MEA Sarcopenia Supplement Share (%), by Country
  • Figure 10. North America Sarcopenia Supplement Share (%), by Country
  • Figure 11. Global Sarcopenia Supplement share by Players 2020 (%)
  • Figure 12. Global Sarcopenia Supplement share by Players (Top 3) 2020(%)
  • Figure 13. Global Sarcopenia Supplement share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Abbott Laborites (United States) Revenue, Net Income and Gross profit
  • Figure 16. Abbott Laborites (United States) Revenue: by Geography 2020
  • Figure 17. Pfizer Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 18. Pfizer Inc.(United States) Revenue: by Geography 2020
  • Figure 19. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 20. Novartis AG (Switzerland) Revenue: by Geography 2020
  • Figure 21. GlaxoSmithKline Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. GlaxoSmithKline Plc (United Kingdom) Revenue: by Geography 2020
  • Figure 23. Nestlé S.A. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Nestlé S.A. (Switzerland) Revenue: by Geography 2020
  • Figure 25. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 27. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 28. Sanofi S.A. (France) Revenue: by Geography 2020
  • Figure 29. Amway(United States) Revenue, Net Income and Gross profit
  • Figure 30. Amway(United States) Revenue: by Geography 2020
  • Figure 31. Cadila Healthcare Ltd.(India) Revenue, Net Income and Gross profit
  • Figure 32. Cadila Healthcare Ltd.(India) Revenue: by Geography 2020
  • Figure 33. Eli Lilly and Company(United States) Revenue, Net Income and Gross profit
  • Figure 34. Eli Lilly and Company(United States) Revenue: by Geography 2020
  • Figure 35. Global Sarcopenia Supplement: by Type USD Million (2021-2026)
  • Figure 36. Global Sarcopenia Supplement: by Distribution Channel USD Million (2021-2026)
  • Figure 37. South America Sarcopenia Supplement Share (%), by Country
  • Figure 38. Asia Pacific Sarcopenia Supplement Share (%), by Country
  • Figure 39. Europe Sarcopenia Supplement Share (%), by Country
  • Figure 40. MEA Sarcopenia Supplement Share (%), by Country
  • Figure 41. North America Sarcopenia Supplement Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laborites (United States)
  • Pfizer Inc.(United States)
  • Novartis AG (Switzerland)
  • GlaxoSmithKline Plc (United Kingdom)
  • Nestlé S.A. (Switzerland)
  • Bayer AG (Germany)
  • Sanofi S.A. (France)
  • Amway(United States)
  • Cadila Healthcare Ltd.(India)
  • Eli Lilly and Company(United States)
Select User Access Type

Key Highlights of Report


Jul 2021 240 Pages 89 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Sarcopenia Supplement Market Quantitative research analysis
Global Sarcopenia Supplement Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increasing Geriatric Population " is seen as one of major growth factors of Sarcopenia Supplement Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
will lead the Sarcopenia Supplement Market.

Know More About Global Sarcopenia Supplement Market Report?

Have a Query? Click Here

Other Related Reports

The Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Comprehensive Study by CRO Service (Discovery, Preclinical, Clinical Service, Laboratory Service), CMO Service (Active Ph...
$ 3750
Roll Compactor Comprehensive Study by Type (• <30Kg/Hour, • 30 – 200Kg/Hour, • >200Kg/Hour), Sales Channel (Online, Offline), End User (Pharmaceutical, Food and Beverage, Chemical, Others) Players an...
$ 3500
VLP Vaccines Comprehensive Study by Virus (Covid-19, Zika, HIV, Adeno-Associated Virus, Hepatitis C), Form (Tablet, Injectables, Capsules, Others), End Use (Hospitals, Specialty Clinics), Vaccine (Li...
$ 3650
Antithyroid Drug Comprehensive Study by Type (Propylthiouracil, Methimazole), Application (Hospital, Specialty Clinics), Distribution Channels (Hospital Dispensary, Retail Pharmacy, Online Pharmacy) ...
$ 3500
Yacon Syrup Comprehensive Study by Type (Conventional, Organic), Application (Household, Commercial), Packaging (Bottle, Can, Pouches, Others), Sales Channel (Online, Offline) Players and Region - Gl...
$ 3500
Nasal Antiseptics Comprehensive Study by Type (Lactoperoxidase, Lactoferrin, Interferons, Povidone- Iodine, Alcohols, Others), Application (Hospitals, Laboratories, Clinics, Others), Sales Channel (O...
$ 3500